EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Gallium(III) Complex Induces Immunogenic Cell Death Hallmarks for Chemoimmunotherapy

Zisis Papadopoulos, Yassin Antar, Irma-Sofie Dieter, Frank Peeters, Carlos Plaza-Sirvent, Johannes Karges iD

Journal of Medicinal Chemistry · 2025

DOI: 10.1021/acs.jmedchem.5c00969 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Zisis Papadopoulos und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Chemistry and Biochemistry, Ruhr-University Bochum, Universitätsstrasse 150, 44780 Bochum, Germany. Hauptthemen laut MEDLINE: Immunogenic Cell Death, Immunotherapy, Antineoplastic Agents, Gallium. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: Verband der Chemischen Industrie, Paul-Ehrlich-Gesellschaft Stiftung, Aventis Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor metastases account for nearly 90% of cancer-related fatalities. To tackle this issue, chemotherapeutic agents that induce immunogenic cell death (ICD) are being investigated as promising candidates for metastatic cancer treatment. Herein, the chemical synthesis and biological evaluation of a novel Ga(III) complex with Schiff bases, [Ga((E)-1-((quinolin-8-ylimino)methyl)naphthalen-2-olato)2][Cl], for potential use in combined chemotherapy and immunotherapy are reported. This compound exhibited broad cytotoxicity against human breast cancer, pancreatic cancer, cervical cancer cell lines, and the noncancerous human fibroblast cell line. Mechanistic investigations revealed that the compound triggers apoptosis and ICD hallmarks, such as translocation of calreticulin, phosphorylation of eIF2α, migration of high mobility group protein 1, and release of adenosine triphosphate. Deeper biological assessment using multicellular tumor spheroids of cervical cancer cell lines, a solid tumor model, demonstrated successful eradication at micromolar concentrations. This study presents one of the few reported Ga(III) complexes capable of inducing immunogenic cell death.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunogenic Cell DeathImmunotherapyAntineoplastic AgentsGalliumCoordination ComplexesHumansCell Line, TumorApoptosisDrug Screening Assays, Antitumor

Substanzen

Antineoplastic AgentsGalliumCoordination Complexes

Autor:innen und Institutionen

  • Faculty of Chemistry and Biochemistry, Ruhr-University Bochum, Universitätsstrasse 150, 44780 Bochum, Germany.
  • Department of Molecular Immunology, Ruhr-University Bochum, Universitätsstrasse 150, 44780 Bochum, Germany.
  • Faculty of Biology and Biotechnology, Ruhr-University Bochum, Universitätsstrasse 150, 44780 Bochum, Germany.

ORCID-Profile: Johannes Karges

Förderung

  • Verband der Chemischen Industrie
  • Paul-Ehrlich-Gesellschaft Stiftung
  • Aventis Foundation

Zitieren

APA

Papadopoulos, Z., Antar, Y., Dieter, I. S., Peeters, F., Plaza-Sirvent, C., & Karges, J. (2025). Gallium(III) Complex Induces Immunogenic Cell Death Hallmarks for Chemoimmunotherapy. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c00969

Vancouver

Papadopoulos Z, Antar Y, Dieter IS, Peeters F, Plaza-Sirvent C, Karges J. Gallium(III) Complex Induces Immunogenic Cell Death Hallmarks for Chemoimmunotherapy. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.5c00969

BibTeX
@article{Papadopoulos2025,
  author = {Papadopoulos, Zisis and Antar, Yassin and Dieter, Irma-Sofie and Peeters, Frank and Plaza-Sirvent, Carlos and Karges, Johannes},
  title = {Gallium(III) Complex Induces Immunogenic Cell Death Hallmarks for Chemoimmunotherapy},
  journal = {Journal of Medicinal Chemistry},
  year = {2025},
  doi = {10.1021/acs.jmedchem.5c00969}
}
Kostenlos starten →